Cargando…

Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study

PURPOSE: To study the cardiovascular death (CVD) risk in primary central nervous system lymphoma (PCNSL) patients with chemotherapy. METHODS: We obtained 2,020 PCNSL participants and 88,613 non-central nervous system lymphoma (NCNSL) participants with chemotherapy from Surveillance, Epidemiology, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Tianwang, Qiu, Zicong, Su, Miao, Yang, Jinming, Tang, Yongshi, Jiang, Yanting, Yao, Dunchen, Lai, Yanxian, Li, Yanfang, Liu, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147725/ https://www.ncbi.nlm.nih.gov/pubmed/34046345 http://dx.doi.org/10.3389/fonc.2021.641955

Ejemplares similares

Cardiovascular Outcomes in the Patients With Primary Central Nervous System Lymphoma: A Multi-Registry Based Cohort Study of 4,038 Cases
por: Qiu, Zicong, et al.
Publicado: (2021)

Increased Risk of Cardiovascular Death in Breast Cancer Patients Without Chemotherapy or (and) Radiotherapy: A Large Population-Based Study
por: Guan, Tianwang, et al.
Publicado: (2021)

Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study
por: Chi, Kaiyi, et al.
Publicado: (2023)

ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus
por: Liu, Cheng, et al.
Publicado: (2018)

Genetic predisposition and bioinformatics analysis of ATP-sensitive potassium channels polymorphisms with the risks of elevated apolipoprotein B serum levels and its related arteriosclerosis cardiovascular disease
por: Liu, Cheng, et al.
Publicado: (2021)

Impact of renin‐angiotensin system inhibitors on long‐term clinical outcomes of patients with rheumatic heart disease
por: Liu, Cheng, et al.
Publicado: (2021)

Association of marital status with cardiovascular outcome in patients with breast cancer
por: Guan, Tianwang, et al.
Publicado: (2022)

Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang
por: Luo, Yi, et al.
Publicado: (2018)

Correction: Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang
por: Luo, Yi, et al.
Publicado: (2019)

Associations of ATP-Sensitive Potassium Channel’s Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes
por: Liu, Cheng, et al.
Publicado: (2022)

ATP-sensitive potassium channels gene polymorphism rs1799858 affects the risk of macro-/micro-vascular arteriosclerotic event in patients with increased low-density lipoprotein cholesterol levels
por: Liu, Cheng, et al.
Publicado: (2020)

Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure: a retrospective study
por: Liu, Cheng, et al.
Publicado: (2020)

Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
por: Wu, H. G., et al.
Publicado: (1999)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
por: Mocikova, Heidi, et al.
Publicado: (2022)

Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
por: Pan, Yizhi, et al.
Publicado: (2018)

Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
por: Sun, Xuefei, et al.
Publicado: (2017)

Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma
por: Sun, Chenjing, et al.
Publicado: (2022)

Efficacy of Procarbazine, Lomustine, and Vincristine Chemotherapy for Recurrent Primary Central Nervous System Lymphomas
por: Kim, Young-Joo, et al.
Publicado: (2015)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

Rare central nervous system lymphomas
por: Kaji, Furqaan Ahmed, et al.
Publicado: (2022)

Research on the Damage of the Central Nervous System Lymphoma to the Nervous System
por: Hernandez, Jairo, et al.
Publicado: (2023)

Association of ACE2 variant rs4646188 with the risks of atrial fibrillation and cardioembolic stroke in Uygur patients with type 2 diabetes
por: Liu, Cheng, et al.
Publicado: (2021)

Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
por: Liu, Cheng, et al.
Publicado: (2021)

Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction
por: Zhang, Shenghui, et al.
Publicado: (2023)

Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma
por: Hu, Rong, et al.
Publicado: (2013)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

Central Nervous System Lymphoma Masquerading as Neurosarcoidosis
por: Arakawa, Akira, et al.
Publicado: (2020)

Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021)

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
por: Ungur, Rodica, et al.
Publicado: (2015)

Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis
por: Ollila, Thomas A., et al.
Publicado: (2023)

How chemotherapy damages the central nervous system
por: Meyers, Christina A
Publicado: (2008)

Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?
por: Matsuo, Toshihiko, et al.
Publicado: (2019)

Intravascular large B-cell lymphoma as a recurrence of primary central nervous system lymphoma after chemotherapy: A case report
por: Edahiro, Yoko, et al.
Publicado: (2021)

Hypopituitarism and Central Diabetes Insipidus Caused by Central Nervous System Lymphoma
por: Zenimaru, Yasuo, et al.
Publicado: (2018)

Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement
por: Mociková, Heidi, et al.
Publicado: (2020)

Mutational analysis of primary central nervous system lymphoma
por: Bruno, Aurélie, et al.
Publicado: (2014)

Unusual relapse of primary central nervous system lymphoma
por: Igala, Marielle
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4rkfcu8d70cjgefp5nu6uhc433